missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ATCAY (aa 273-369) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (81%), Rat (81%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-53636 (PA5-53636. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
This gene encodes a neuron-restricted protein that contains a CRAL-TRIO motif common to proteins that bind small lipophilic molecules. Mutations in this gene are associated with cerebellar ataxia, Cayman type.
Specifications
Specifications
| Accession Number | Q86WG3 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 85300 |
| Name | Human ATCAY (aa 273-369) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 3322401A10Rik; ataxia cayman type protein; ataxia cerebellar Cayman type; ataxia, cerebellar, Cayman type; ataxia, cerebellar, Cayman type homolog (human); Atcay; ATCAY, caytaxin; BB077577; BNIP-2-homolgy; BNIP-2-homology; BNIP-H; Cayman ataxia; caytaxin; CLAC; hes; hesitant; ji; jittery; KIAA1872 |
| Common Name | ATCAY |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction